Castle Biosciences (CSTL) Investor Presentation - Slideshow
CSTLCastle Biosciences(CSTL)2023-03-23 03:00

Transforming Disease Management March 2023 Disclaimers Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. These forward-looking statements include, but are not limited to, statements concerning: generating between $170-180 million in total revenue in 2023; estimated size ...